Apollo Hospitals Enterprise Ltd: Technical Momentum Shifts Amid Mixed Indicator Signals

Technical Trend and Momentum Overview

Apollo Hospitals’ technical trend has shifted from a neutral sideways pattern to a mildly bearish one, signalling a subtle change in market sentiment. The daily moving averages have turned mildly bearish, suggesting that short-term price momentum is weakening. However, weekly and monthly indicators present a more nuanced picture. The weekly MACD remains bullish, indicating that medium-term momentum is still positive, while the monthly MACD has turned mildly bearish, reflecting some caution among longer-term investors.

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in neutral zones without indicating overbought or oversold conditions. This lack of extreme RSI readings suggests that the stock is not currently in a momentum exhaustion phase, leaving room for potential directional moves.

Bollinger Bands and KST Indicators

Bollinger Bands provide further insight into volatility and price action. On a weekly basis, the bands are bullish, implying that price is trending towards the upper band and volatility is supportive of upward movement. Conversely, the monthly Bollinger Bands are mildly bullish, indicating a cautiously optimistic longer-term outlook. The Know Sure Thing (KST) oscillator, which measures momentum across multiple timeframes, is mildly bullish on the weekly chart but mildly bearish on the monthly chart. This divergence highlights a tension between short- and long-term momentum forces.

Volume and Dow Theory Signals

On-Balance Volume (OBV) and Dow Theory indicators show no definitive trend on either weekly or monthly timeframes. The absence of volume confirmation and trend signals from these classical tools suggests that the current price movements may lack strong conviction from market participants, warranting a cautious approach.

Price Performance Relative to Benchmarks

Despite the mixed technical signals, Apollo Hospitals has delivered robust returns relative to the broader market. Over the past week, the stock’s return was marginally negative at -0.04%, outperforming the Sensex’s decline of 3.33%. Over one month, the stock surged 8.01% while the Sensex fell 7.73%. Year-to-date, Apollo Hospitals has gained 10.6%, significantly ahead of the Sensex’s 8.98% loss. The one-year return of 25.31% further underscores the stock’s strong performance, compared to the Sensex’s modest 4.35% gain. Longer-term returns are even more impressive, with a three-year gain of 76.36% versus 29.7% for the Sensex, and a five-year return of 169.66% compared to 52.01% for the benchmark. Over a decade, Apollo Hospitals has delivered a remarkable 458.68% return, more than doubling the Sensex’s 212.84%.

Current Price Action and Key Levels

Apollo Hospitals closed at ₹7,789.10 on 10 Mar 2026, up 0.86% from the previous close of ₹7,722.95. The intraday high was ₹7,809.10 and the low ₹7,564.85, indicating some volatility but overall positive momentum during the session. The stock remains below its 52-week high of ₹8,099.00 but comfortably above the 52-week low of ₹6,017.95, reflecting a strong recovery and sustained investor interest.

Mojo Score and Grade Revision

MarketsMOJO assigns Apollo Hospitals a Mojo Score of 55.0, categorising it as a Hold. This represents a downgrade from a previous Buy rating as of 09 Jan 2026. The downgrade reflects the recent shift in technical parameters and the mixed signals from key indicators. The Market Cap Grade remains at 1, indicating a large-cap status but with limited momentum improvement. Investors should weigh this Hold rating against the stock’s strong fundamental performance and relative outperformance versus the Sensex.

Technical Indicator Summary

The daily moving averages have turned mildly bearish, signalling short-term caution. Weekly MACD remains bullish, supporting medium-term strength, while monthly MACD’s mild bearishness suggests some longer-term pressure. RSI readings on weekly and monthly charts are neutral, indicating no immediate overbought or oversold conditions. Bollinger Bands show weekly bullishness and mild monthly bullishness, suggesting volatility is currently supportive of price gains. KST oscillators present a split view with weekly mildly bullish and monthly mildly bearish readings. Dow Theory and OBV indicators show no clear trend, implying a lack of strong volume confirmation.

Implications for Investors

The mixed technical signals imply that Apollo Hospitals is at a crossroads. The mildly bearish daily moving averages and monthly MACD caution investors to monitor for potential downside risks. However, the weekly bullish MACD and Bollinger Bands, combined with the stock’s strong relative returns, suggest underlying strength that could support further gains if momentum stabilises. Neutral RSI readings indicate the stock is not currently stretched, allowing room for directional moves in either direction.

Investors should consider the Hold rating in the context of their portfolio objectives and risk tolerance. Those with a medium- to long-term horizon may find the stock’s strong historical returns and relative outperformance attractive, while short-term traders should watch for confirmation of trend direction from moving averages and momentum oscillators.

Conclusion: Navigating Mixed Signals with Caution

Apollo Hospitals Enterprise Ltd. currently exhibits a complex technical profile with a shift towards mild bearishness in short-term indicators, while medium-term signals remain cautiously optimistic. The stock’s strong relative performance against the Sensex and its large-cap stature provide a solid fundamental backdrop. However, the downgrade to a Hold rating by MarketsMOJO reflects the need for investors to exercise prudence amid the mixed momentum signals.

Monitoring key technical levels, particularly the behaviour of moving averages and MACD on weekly and monthly charts, will be critical in assessing whether the stock can regain bullish momentum or if further downside pressure will materialise. For now, Apollo Hospitals remains a stock to watch closely, balancing its historical strength with emerging technical caution.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →